World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
39535
World Ranking
9556
National Ranking
328

Overview

Maria Trojano is affiliated with the University of Bari Aldo Moro in Italy. Their research primarily focuses on Medicine, with significant contributions spanning Pathology and Forensic Medicine, Neurology, Oncology, Rheumatology, and Public Health, Environmental and Occupational Health.

The scientist's work covers a broad range of topics, including:

  • Multiple Sclerosis Research Studies
  • Peripheral Neuropathies and Disorders
  • Polyomavirus and related diseases
  • Rheumatoid Arthritis Research and Therapies
  • Acute Lymphoblastic Leukemia research
  • Long-Term Effects of COVID-19
  • SARS-CoV-2 and COVID-19 Research

Frequent publication venues for Maria Trojano include:

  • Neurology
  • Multiple Sclerosis Journal
  • Journal of Neurology
  • Journal of the Neurological Sciences
  • Neurological Sciences

Frequent co-authors collaborating with Trojano are:

  • Francesco Patti
  • Maria Pia Amato
  • Pietro Iaffaldano
  • Massimo Filippi
  • Franco Granella

Some of the recent papers associated with this researcher include:

  • Multiple sclerosis progression: time for a new mechanism-driven framework, 2022, The Lancet Neurology
  • Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis, 2021, Annals of Neurology
  • Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study, 2020, The Lancet Neurology
  • Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP), 2020, Journal of Neurology Neurosurgery & Psychiatry
  • Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinion, 2022, Journal of Neurology

Best Publications

  • Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

    Alan J. Thompson;Brenda L. Banwell;Frederik Barkhof;Frederik Barkhof;William M. Carroll

  • Multiple Sclerosis Severity Score: Using disability and disease duration to rate disease severity

    R. H.S.R. Roxburgh;S. R. Seaman;T. Masterman;A. E. Hensiek

  • Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.

    M. Andersson;J. Alvarezcermeno;G. Bernardi;I. Cogato

  • The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review

    Ruth Ann M Marrie;Stephen Reingold;Jeffrey A Cohen;Olaf Stuve

  • Association of Initial Disease-Modifying Therapy with Later Conversion to Secondary Progressive Multiple Sclerosis

    J. William L. Brown;J. William L. Brown;J. William L. Brown;Alasdair Coles;Dana Horakova;Eva Havrdova

  • Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.

    Maria Pia Sormani;Nicola De Rossi;Irene Schiavetti;Luca Carmisciano

  • A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview

    Ruth Ann M Marrie;Jeffrey A Cohen;Olaf Stuve;Maria Trojano

  • Defining secondary progressive multiple sclerosis.

    Johannes Lorscheider;Johannes Lorscheider;Katherine Buzzard;Katherine Buzzard;Katherine Buzzard;Vilija G Jokubaitis;Vilija G Jokubaitis;Tim Spelman

  • Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study.

    Anna He;Bernd Merkel;James William L Brown;James William L Brown;James William L Brown;Lana Zhovits Ryerson

  • The Rao’s Brief Repeatable Battery and Stroop test: normative values with age, education and gender corrections in an Italian population:

    M P Amato;E Portaccio;B Goretti;V Zipoli

  • Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome

    E Millefiorini;C Gasperini;C Pozzilli;F D'Andrea

  • Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica.

    Angelo Ghezzi;Roberto Bergamaschi;Vittorio Martinelli;Maria Trojano

  • New natural history of interferon‐β–treated relapsing multiple sclerosis

    Maria Trojano;Fabio Pellegrini;Aurora Fuiani;Damiano Paolicelli

  • The prevalence of pain in multiple sclerosis: A multicenter cross-sectional study

    C. Solaro;G. Brichetto;M. P. Amato;E. Cocco

  • Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study

    J. Kuhle;G. Disanto;R. Dobson;R. Adiutori

  • Cognitive and psychosocial features of childhood and juvenile MS

    M. P. Amato;B. Goretti;A. Ghezzi;S. Lori

  • Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes.

    Luis Ruano;Emilio Portaccio;Benedetta Goretti;Claudia Niccolai

  • Cognitive and psychosocial features in childhood and juvenile MS Two-year follow-up

    M. P. Amato;B. Goretti;A. Ghezzi;S. Lori

  • Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study

    F Patti;MP Amato;M Trojano;S Bastianello

  • Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis

    Maria Trojano;Guglielmo Lucchese;Giusi Graziano;Bruce V. Taylor

Frequent Co-Authors

Helmut Butzkueven
Helmut Butzkueven Monash University
Maria Pia Amato
Maria Pia Amato University of Florence
Paolo Livrea
Paolo Livrea University of Bari Aldo Moro
Raymond Hupperts
Raymond Hupperts Maastricht University
Eva Havrdova
Eva Havrdova Charles University
Alexandre Prat
Alexandre Prat University of Montreal
Ludwig Kappos
Ludwig Kappos University Hospital of Basel
Carlo Pozzilli
Carlo Pozzilli Sapienza University of Rome
Giancarlo Comi
Giancarlo Comi Vita-Salute San Raffaele University
Heinz Wiendl
Heinz Wiendl University of Münster

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in healthcare can open doors for students interested in medicine but seeking flexible or less traditional options. For those aiming to jumpstart their nursing careers, there are easy nursing schools to get into that offer accessible admission policies and supportive learning environments.

If you prefer working behind the scenes, medical billing and coding is a growing field, and there are accredited medical billing and coding schools online with financial aid to help get you started without the burden of heavy student loans.

Upgrading nursing qualifications is another popular pathway. For Licensed Practical Nurses (LPNs) looking to advance, explore lpn to rn programs without teas test. These programs can sometimes streamline the transition without requiring additional standardized exams.

Finally, for future leaders, accelerated online programs in healthcare administration are available. Consider enrolling in the healthcare administration accelerated degree that can prepare you for advanced roles in a fraction of the time.

Best Scientists Citing Maria Trojano

Trending Scientists

Recently Published Articles